Related Experiment Video
Updated: Jun 20, 2025

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
Elucidating the nexus between onco-immunology and kidney transplantation: An insight from precision medicine
Athaya Febriantyo Purnomo1,2, Fahrul Nurkolis3, Rony Abdi Syahputra4
1Department of Oncology, University of Oxford, Oxford, OX3 7DQ, United Kingdom.
Abstract:
The interplay of onco-immunology and kidney transplantation heralds a transformative era in medical science. This integration, while promising, presents significant challenges. Chief among these is the dichotomy of immunosuppression-boosting immunity against malignancies while suppressing it for graft survival. Additionally, limited clinical data on novel therapies, genetic variations influencing responses, economic concerns, and the narrow therapeutic window for post-transplant malignancies necessitate strategic addressal. Conversely, opportunities abound, including personalized immune monitoring, targeted therapies, minimized immunosuppression, and improved patient quality of life. Emphasizing collaborative research and interdisciplinary cooperation, the merging of these fields offers the potential for enhanced graft survival and reduced post-transplant malignancy risks. As we harness modern technology and promote patient-centric care, the vision for the future of kidney transplantation becomes increasingly hopeful, paving the way for more personalized and effective treatments. The article aims to elucidate the critical challenge of balancing immunosuppression to simultaneously combat malignancies and ensure graft survival. It addresses the scarcity of clinical data on novel therapies, the impact of genetic variations on treatment responses, and the economic and therapeutic concerns in managing post-transplant malignancies. Furthermore, it explores the opportunities precision medicine offers, such as personalized immune monitoring, targeted therapies, and reduced immunosuppression, which could significantly improve patient outcomes. Highlighting the importance of collaborative research and interdisciplinary efforts, the article seeks to demonstrate the potential for enhanced graft survival and reduced post-transplant malignancy risks. By leveraging modern technology and prioritizing patient-centric care, it envisions a future where kidney transplantation is more personalized and effective, offering hope for advancements in this field.
Insights
Balancing immunosuppression is key in kidney transplantation to fight cancer while ensuring graft survival. Personalized monitoring and targeted therapies offer hope for better outcomes.
Area of Science:
- Onco-immunology
- Transplantation Science
- Immunology
Background:
- The integration of onco-immunology and kidney transplantation presents a dual challenge: using immunosuppression to combat malignancies while preventing graft rejection.
- Limited clinical data, genetic factors, economic issues, and narrow therapeutic windows complicate the management of post-transplant malignancies.
Purpose of the Study:
- To elucidate the critical challenge of balancing immunosuppression for both malignancy control and graft survival in kidney transplant recipients.
- To address the scarcity of clinical data on novel therapies and the impact of genetic variations on treatment responses.
- To explore opportunities in precision medicine for improved patient outcomes.
Main Methods:
- Review of current literature on onco-immunology and kidney transplantation.
- Analysis of challenges including immunosuppression dichotomy, limited clinical data, and genetic influences.
- Exploration of opportunities such as personalized immune monitoring and targeted therapies.
Main Results:
- The dichotomy of immunosuppression poses a significant challenge, requiring careful balancing for onco-immunology and graft survival.
- Personalized immune monitoring, targeted therapies, and minimized immunosuppression are promising avenues for improving patient quality of life.
- Collaborative research and interdisciplinary cooperation are crucial for advancing the field.
Conclusions:
- Enhanced graft survival and reduced post-transplant malignancy risks are achievable through strategic integration of onco-immunology and kidney transplantation.
- Leveraging modern technology and patient-centric care can lead to more personalized and effective treatments.
- The future of kidney transplantation holds promise for improved outcomes by addressing current challenges and embracing innovative approaches.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

